Principal Financial Group Inc. Increases Its Investment in Vericel Co. (NASDAQ:VCEL)

2 min read | February 27, 2025 12:29 AM PST | By Team Kalkine Media

Highlight

  • Principal Financial Group Inc. raised its stake in Vericel Co. by 4.4% during the fourth quarter.
  • Vericel Co.'s stock saw multiple institutional investments and changes in positions.
  • Market analysts generally project a positive outlook with an average target price of $63.14.

Principal Financial Group Inc. has steadily increased its holdings in Vericel Co. (NASDAQ:VCEL), enhancing its stake by 4.4% in the fourth quarter. This adjustment raises the fund’s stake to 262,932 shares, equivalent to 0.53% ownership of Vericel, valued at approximately $14,438,000 at the close of the quarter. Various other institutional investors also altered their stakes, signaling growing interest and potential confidence in Vericel Co.

Other Key Stakeholder Movements

Other influential changes in positions include the Louisiana State Employees Retirement System, which marginally increased its holdings by 0.8%. Similarly, Mirae Asset Global Investments Co., Ltd. experienced a 22.2% boost in its stake, and Farther Finance Advisors LLC enjoyed a substantial 48.1% rise in its shares. These strategic moves suggest a broader interest within the institutional investment sector towards Vericel.

Market Insights and Stock Analysis

Shares of Vericel began trading at $52.85, with varying analyst opinions supporting a promising trajectory. The stock is noted for its 52-week range between $39.12 to $63.00. Analysts from multilateral research firms have consistently expressed encouraging forecasts, citing anticipated price growth. Among them, HC Wainwright and BTIG Research forecast favorable price objectives, indicating confidence in future performance.

Insider Transactions and Company Profile

Recent insider trading within Vericel Co. included significant sales by insiders Jonathan Seigal and Jonathan Mark Hopper. These transactions highlight shifts in internal stake distribution but are accompanied by strategic market activities that may influence stock valuation. Vericel Co., distinguished as a pioneering biopharmaceutical entity, occupies a unique position in the cellular therapeutic landscape, contributing substantially to sports medicine and severe burn care markets.

For further details on hedge funds' activities and to keep abreast of the latest 13F filings along with company insider trading, visit HoldingsChannel.com. Stay updated with the evolving trends and insights into Vericel Co. (NASDAQ:VCEL), as market dynamics continue to unfold.


Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media LLC (Kalkine Media, we or us) and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary. Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures/music displayed/used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source (public domain/CC0 status) to where it was found and indicated it, as necessary.


Sponsored Articles


Investing Ideas

Previous Next